Trial Profile
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Nov 2017
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 08 Dec 2011 New trial record